Shattuck Labs (STTK) Profit After Tax (2019 - 2026)
Shattuck Labs (STTK) reported Profit After Tax of -$14.8 million for Q1 2026, down 7.77% year-over-year from -$16.0 million in Q1 2025, and down 17.26% quarter-over-quarter from -$12.6 million in Q4 2025.
Shattuck Labs (STTK) Profit After Tax (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Profit After Tax data on file, last reported at -$14.8 million in Q1 2026.
- Profit After Tax for Q1 2026 came in at -$14.8 million, down 7.77% year-over-year; the trailing twelve-month figure through Mar 2026 was -$49.9 million (up 29.36% YoY), and the FY2025 annual result was -$48.8 million, up 35.28% from the prior year.
- Profit After Tax fell to -$14.8 million in Q1 2026 per STTK's latest filing, from -$12.6 million in the prior quarter.
- Over five years, Profit After Tax peaked at -$10.1 million in Q3 2025 and troughed at -$27.5 million in Q3 2023.
- A 5-year average of -$19.3 million and a median of -$18.7 million in 2024 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2022 and 2025: Profit After Tax plunged 423.83% in 2022, then jumped 42.2% in 2025.
- A 5-year view of Profit After Tax shows it stood at -$25.4 million in 2022, then jumped by 30.4% to -$17.7 million in 2023, then declined by 5.61% to -$18.7 million in 2024, then surged by 32.58% to -$12.6 million in 2025, then slipped by 17.26% to -$14.8 million in 2026.
- Business Quant data shows STTK's Profit After Tax at -$14.8 million in Q1 2026, -$12.6 million in Q4 2025, and -$10.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Shattuck Labs | 190.32 Mn | 190.32 Mn | - | -14.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.77 Mn |
| Dec 31, 2025 | -12.59 Mn |
| Sep 30, 2025 | -10.06 Mn |
| Jun 30, 2025 | -12.46 Mn |
| Mar 31, 2025 | -13.70 Mn |
| Dec 31, 2024 | -18.68 Mn |
| Sep 30, 2024 | -16.68 Mn |
| Jun 30, 2024 | -21.55 Mn |
| Mar 31, 2024 | -18.50 Mn |
| Dec 31, 2023 | -17.69 Mn |
| Sep 30, 2023 | -27.54 Mn |
| Jun 30, 2023 | -21.35 Mn |
| Mar 31, 2023 | -20.72 Mn |
| Dec 31, 2022 | -25.41 Mn |
| Sep 30, 2022 | -24.64 Mn |
| Jun 30, 2022 | -27.37 Mn |
| Mar 31, 2022 | -24.53 Mn |
| Dec 31, 2021 | 7.85 Mn |
| Sep 30, 2021 | -17.41 Mn |
| Jun 30, 2021 | -23.60 Mn |